Publicaciones científicas
Rna-loaded nanoparticles for the treatment of hematological cancers
Elisa Garbayo 1 , Souhaila H El Moukhtari 2 , Carlos Rodríguez-Nogales 1 , Xabier Agirre 3 , Juan R Rodriguez-Madoz 3 , Paula Rodriguez-Marquez 3 , Felipe Prósper 4 , Patrick Couvreur 5 , María J Blanco-Prieto 6
Abstract
Hematological cancers encompass a diverse group of malignancies affecting the blood, bone marrow, lymph nodes, and spleen. These disorders present unique challenges due to their complex etiology and varied clinical manifestations. Despite significant advancements in understanding and treating hematological malignancies, innovative therapeutic approaches are continually sought to enhance patient outcomes.
This review highlights the application of RNA nanoparticles (RNA-NPs) in the treatment of hematological cancers. We delve into detailed discussions on in vitro and preclinical studies involving RNA-NPs for adult patients, as well as the application of RNA-NPs in pediatric hematological cancer.
The review also addresses ongoing clinical trials involving RNA-NPs and explores the emerging field of CAR-T therapy engineered by RNA-NPs.
Finally, we discuss the challenges still faced in translating RNA-NP research to clinics.
CITA DEL ARTÍCULO Adv Drug Deliv Rev. 2024 Sep 18:214:115448. doi: 10.1016/j.addr.2024.115448
Nuestros autores
